As biotech IPOs hit a record low in the US, more than 40 Chinese biopharma companies have filed to go public so far this year …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Visited 1 times, 1 visit(s) today
